These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38486935)

  • 21. PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP.
    Bensalma S; Turpault S; Balandre AC; De Boisvilliers M; Gaillard A; Chadéneau C; Muller JM
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retraction: ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway.
    Yin H; Wang L; Li F; Wang D; Zhang Z; Yu B; Liu Y
    Transl Cancer Res; 2023 Nov; 12(11):3222. PubMed ID: 38130303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction: Daphnetin inhibits proliferation and glycolysis in colorectal cancer cells by regulating the PI3K/Akt signaling pathway.
    Fisher L
    RSC Adv; 2021 Jan; 11(9):5023. PubMed ID: 35686057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis.
    Pagano A; Breuzard G; Parat F; Tchoghandjian A; Figarella-Branger D; De Bessa TC; Garrouste F; Douence A; Barbier P; Kovacic H
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis
    Guo J; Zhang S; Wang J; Zhang P; Lu T; Zhang L
    Front Oncol; 2022; 12():970020. PubMed ID: 35865466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retraction: The novel tumor suppressor gene ZNF24 induces THCA cells senescence by regulating Wnt signaling pathway resulting in inhibition of THCA tumorigenesis and invasion.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1443826. PubMed ID: 38957314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retraction: FOXC1 silencing promotes A549 cell apoptosis through inhibiting the PI3K/AKT/hedgehog/Gli2 signaling pathway.
    Fisher L
    RSC Adv; 2021 Jan; 11(8):4572. PubMed ID: 35747607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma
    Yu CC; Hung SK; Lin HY; Chiou WY; Lee MS; Liao HF; Huang HB; Ho HC; Su YC
    Oncotarget; 2017 Sep; 8(40):68641-68653. PubMed ID: 28978144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-Induced Aquaporin-3 Changes Hepatocellular Carcinoma Cell Sensitivity to Sorafenib by Activating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():9027-9028. PubMed ID: 34916846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA1 Gene Silencing Inhibits Invasion, Proliferation and Migration of Cholangiocarcinoma Stem Cells via Disrupting the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1005. PubMed ID: 33603406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation.
    Kao GD; Jiang Z; Fernandes AM; Gupta AK; Maity A
    J Biol Chem; 2007 Jul; 282(29):21206-12. PubMed ID: 17513297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53.
    Li Z; Xu X; Li Y; Zou K; Zhang Z; Xu X; Liao Y; Zhao X; Jiang W; Yu W; Guo W; Chen Y; Li Y; Chen M; Deng WG; Li L; Zou L
    Cell Physiol Biochem; 2018; 45(5):1772-1786. PubMed ID: 29495002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retraction: Down-regulation of HOXB5 inhibits TGF-β-induced migration and invasion in hepatocellular carcinoma cells
    Sun JP; Ge QX; Ren Z; Sun XF; Xie SP
    RSC Adv; 2022 Sep; 12(43):27996. PubMed ID: 36320248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity.
    Seol MY; Choi SH; Lee IJ; Park HS; Kim HR; Kim SK; Yoon HI
    Yonsei Med J; 2023 Feb; 64(2):139-147. PubMed ID: 36719022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction].
    Int J Gen Med; 2023; 16():5159-5160. PubMed ID: 37954653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction: Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
    Oncotarget; 2019 Jun; 10(41):4252. PubMed ID: 31289623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.